Crescendo Bioscience, Inc. Ranked Number 27th Fastest Growing Company in North America on Deloitte's 2013 Technology Fast 500(TM)
November 13, 2013 05:05 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a molecular diagnostics company dedicated to developing quantitative blood tests and disease information services...
Crescendo Bioscience Increases Presence at the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting
October 28, 2013 09:00 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a molecular diagnostics company dedicated to developing and commercializing quantitative blood tests for rheumatoid...
Inc. Magazine Ranks Crescendo Bioscience as the 67th Fastest Growing Private Company in the United States
August 22, 2013 11:54 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., Aug. 22, 2013 (GLOBE NEWSWIRE) -- Inc. magazine has announced that Crescendo Bioscience is the 67th fastest growing private company in the United States, according to its...
Crescendo Bioscience(R) Announces Medicare Coverage for Vectra(R) DA to Measure Disease Activity in Patients With Rheumatoid Arthritis
July 08, 2013 09:00 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience, Inc., a molecular diagnostics company dedicated to developing quantitative blood tests and disease information...
Crescendo Bioscience to Present New Data on Vectra(R) DA Use to Assess Radiographic Progression Risk in Patients With Rheumatoid Arthritis Treated With Traditional and Biologic Therapies at the European League Against Rheumatism Annual Meeting (EULAR)
June 12, 2013 06:00 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., June 12, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a molecular diagnostics company dedicated to developing and commercializing quantitative blood tests for rheumatoid...
Crescendo Bioscience Selected for the Red Herring 2013 Top 100 North America Award
May 30, 2013 09:00 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., May 30, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience®, Inc., a molecular diagnostics company dedicated to developing quantitative blood tests and disease information...
Crescendo Bioscience Receives Accreditation from the College of American Pathologists
May 01, 2013 09:00 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a molecular diagnostics company developing and commercializing quantitative, biology-based tests for rheumatoid...
Crescendo Bioscience(R) Announces Laboratory Clearance for Use of Vectra(R) DA in New York State
April 18, 2013 09:00 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., April 18, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience®, a molecular diagnostics company developing and commercializing quantitative, biology-based tests for...
Crescendo Bioscience to Participate in the Buzz of BIO at the 2013 BIO International Convention
March 28, 2013 14:33 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., March 28, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience is pleased to participate in the Buzz of BIO, at the 2013 BIO International Convention. Hosted by the Biotechnology...
Photo Release -- Crescendo Bioscience(R) Announces Global Launch of Innovative iPhone App to Help Track Rheumatoid Arthritis
March 11, 2013 12:01 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., March 11, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience®, Inc., a molecular diagnostics company dedicated to developing quantitative blood tests and disease...